Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks

OBJECTIVE: To evaluate the efficacy and safety of golimumab 50 and 100 mg monotherapy in Japanese patients with active rheumatoid arthritis (RA) despite treatment with disease-modifying antirheumatic drugs (DMARDs). METHODS: A total of 316 patients were randomised to receive subcutaneous injections...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Takeuchi, Tsutomu, Harigai, Masayoshi, Tanaka, Yoshiya, Yamanaka, Hisashi, Ishiguro, Naoki, Yamamoto, Kazuhiko, Miyasaka, Nobuyuki, Koike, Takao, Kanazawa, Minoru, Oba, Takuya, Yoshinari, Toru, Baker, Daniel
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2013
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3756456/
https://ncbi.nlm.nih.gov/pubmed/22984173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2012-201796
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados